Challenges in the Ethical Review of Research Involving Complementary and Integrative Medicine

Jeffrey A. Cooper, David Borasky, Stephen Rosenfeld, Jeremy Sugarman

Research output: Contribution to journalArticle

Abstract

Complementary and integrative medicine (CIM) involves using practices outside mainstream Western medicine, often derived from Eastern traditional medicine, and combining those practices with Western medicine. Conducting CIM research that is necessary to determine whether particular interventions are beneficial and safe will involve a set of ethical challenges. Institutional review boards (IRBs), also known as research ethics committees or research ethics boards, are responsible for determining that research studies involving human subjects appropriately address ethical and regulatory concerns inherent to the research. Like other research with human subjects, research involving CIM is subject to ethical review and ongoing oversight by an IRB. IRBs are often challenged by the review of CIM. These challenges include accounting for cultural differences and the interests of competing stakeholders. In this report, we describe these issues that were the focus of a workshop that was part of an international conference held in Seoul, Korea, on April 4, 2015.

Original languageEnglish (US)
Pages (from-to)337-341
Number of pages5
JournalTherapeutic Innovation and Regulatory Science
Volume50
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Ethical Review
Integrative Medicine
Complementary Therapies
Research Ethics Committees
Research
Medicine
Research Ethics
Traditional Medicine
Korea
Education

Keywords

  • complementary and alternative medicine
  • ethical review
  • Korea
  • traditional medicine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Public Health, Environmental and Occupational Health
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Challenges in the Ethical Review of Research Involving Complementary and Integrative Medicine. / Cooper, Jeffrey A.; Borasky, David; Rosenfeld, Stephen; Sugarman, Jeremy.

In: Therapeutic Innovation and Regulatory Science, Vol. 50, No. 3, 2015, p. 337-341.

Research output: Contribution to journalArticle

@article{565209ad58d24e0ea334b10cfc678b9a,
title = "Challenges in the Ethical Review of Research Involving Complementary and Integrative Medicine",
abstract = "Complementary and integrative medicine (CIM) involves using practices outside mainstream Western medicine, often derived from Eastern traditional medicine, and combining those practices with Western medicine. Conducting CIM research that is necessary to determine whether particular interventions are beneficial and safe will involve a set of ethical challenges. Institutional review boards (IRBs), also known as research ethics committees or research ethics boards, are responsible for determining that research studies involving human subjects appropriately address ethical and regulatory concerns inherent to the research. Like other research with human subjects, research involving CIM is subject to ethical review and ongoing oversight by an IRB. IRBs are often challenged by the review of CIM. These challenges include accounting for cultural differences and the interests of competing stakeholders. In this report, we describe these issues that were the focus of a workshop that was part of an international conference held in Seoul, Korea, on April 4, 2015.",
keywords = "complementary and alternative medicine, ethical review, Korea, traditional medicine",
author = "Cooper, {Jeffrey A.} and David Borasky and Stephen Rosenfeld and Jeremy Sugarman",
year = "2015",
doi = "10.1177/2168479015620246",
language = "English (US)",
volume = "50",
pages = "337--341",
journal = "Therapeutic Innovation and Regulatory Science",
issn = "2168-4790",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Challenges in the Ethical Review of Research Involving Complementary and Integrative Medicine

AU - Cooper, Jeffrey A.

AU - Borasky, David

AU - Rosenfeld, Stephen

AU - Sugarman, Jeremy

PY - 2015

Y1 - 2015

N2 - Complementary and integrative medicine (CIM) involves using practices outside mainstream Western medicine, often derived from Eastern traditional medicine, and combining those practices with Western medicine. Conducting CIM research that is necessary to determine whether particular interventions are beneficial and safe will involve a set of ethical challenges. Institutional review boards (IRBs), also known as research ethics committees or research ethics boards, are responsible for determining that research studies involving human subjects appropriately address ethical and regulatory concerns inherent to the research. Like other research with human subjects, research involving CIM is subject to ethical review and ongoing oversight by an IRB. IRBs are often challenged by the review of CIM. These challenges include accounting for cultural differences and the interests of competing stakeholders. In this report, we describe these issues that were the focus of a workshop that was part of an international conference held in Seoul, Korea, on April 4, 2015.

AB - Complementary and integrative medicine (CIM) involves using practices outside mainstream Western medicine, often derived from Eastern traditional medicine, and combining those practices with Western medicine. Conducting CIM research that is necessary to determine whether particular interventions are beneficial and safe will involve a set of ethical challenges. Institutional review boards (IRBs), also known as research ethics committees or research ethics boards, are responsible for determining that research studies involving human subjects appropriately address ethical and regulatory concerns inherent to the research. Like other research with human subjects, research involving CIM is subject to ethical review and ongoing oversight by an IRB. IRBs are often challenged by the review of CIM. These challenges include accounting for cultural differences and the interests of competing stakeholders. In this report, we describe these issues that were the focus of a workshop that was part of an international conference held in Seoul, Korea, on April 4, 2015.

KW - complementary and alternative medicine

KW - ethical review

KW - Korea

KW - traditional medicine

UR - http://www.scopus.com/inward/record.url?scp=84964262329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964262329&partnerID=8YFLogxK

U2 - 10.1177/2168479015620246

DO - 10.1177/2168479015620246

M3 - Article

AN - SCOPUS:84964262329

VL - 50

SP - 337

EP - 341

JO - Therapeutic Innovation and Regulatory Science

JF - Therapeutic Innovation and Regulatory Science

SN - 2168-4790

IS - 3

ER -